Ask Questions About Clinical Trials (ASQ-CT)

Barbara Ann Karmanos Cancer Institute

Status: Begins enrollment in 2 months

Conditions: Oncology; Cardiac Disease; Neurologic Disorder

Treatments: Behavioral: Ask Questions about Clinical Trials brochure

Study type: Interventional

Funder types: Other

Identifiers

NCT07343297

2025-082

Details and patient eligibility

About

The overall goal of this study is to assess the implementation of the Ask Questions about Clinical Trials (ASQ-CT) brochure, a patient-focused communication tool previously demonstrated to improve patient-provider communication about clinical trials. Participants will be given the ASQ-CT brochure at Time 1 (baseline) and participants will complete a questionnaire at three timepoints, baseline (Time 1), Pre-Research Visit (Time 2), and Post-Research Visit (Time 3).

Enrollment: 293 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age > or equal to 18 years
• Appointment to see a provider at a Karmanos Cancer Institute-McLaren or a medical encounter at McLaren Center for Research and Innovation (MCRI) site for medical/systemic treatment
• Potentially eligible for a clinical trial
• Speak and read English well enough to be able to understand consent documents and complete surveys

Exclusion criteria

• Not able to complete study documents on their own physically or cognitively

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

293 participants in 1 patient group

Ask Questions about Clinical Trials (ASQ-CT) Brochure

Experimental group

Description:

Ask Questions about Clinical Trials (ASQ-CT), a clinical trial communication intervention brochure

Treatment:

Behavioral: Ask Questions about Clinical Trials brochure